ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Park Medi World Investor Presentation: Key Takeaways

Park Medi World reports strong Q1 FY27 results with 19% YoY revenue growth and 35% PAT growth. Strategy focuses on North India cluster expansion through acquisitions and greenfield projects.

Highlights
Revenue growth19% YoY
MarginsEBITDA margin stable at 26.5%; PAT margin expanded 220 bps YoY.
Demand visibilityStrong; addressing 3mn bed supply gap in North India.
Management confidenceHigh; expanding to 6 states with roadmap for 5,740 beds.

Growth

Revenue grew 19% YoY to INR 4,757 mn; PAT rose 35% to INR 886 mn. Patient volume increased 17%.

Outlook

Targeting 5,740 beds by FY28 via INR 177Cr Rudrapur and INR 107Cr Zirakpur acquisitions. Capex funded via internal accruals.

Risks

Occupancy moderated to 55.6% due to significant capacity addition; high reliance on North Indian markets.

Last quarter's promises, checked

Delivered

  • Guided Q2 FY27 Narela commissioning → delivered on track (= BEAT)
  • Guided 5,460 beds by March 2028 → expanded target to 5,740 (= BEAT)
  • Guided EBITDA positive Agra/Bathinda → delivered operational ramp-up (= BEAT)

Missed

  • Implicitly guided stable occupancy → delivered 55.6% vs 64.1% FY26 (= MISS)
Source

Investor Presentation filed with BSE, NSE: PARKHOSPS. Summary written with AI assistance from the document.

Read the document ↗

Park Medi World Ltd: key numbers

Share price
₹257.49
Market cap
₹11,122 Cr
Revenue (annual)
₹1,679 Cr
Net profit (annual)
₹258.1 Cr
P/E (TTM)
40.0×Sector 54.5×
Promoter holding
82.90%+0.01% QoQ
FII holding
0.88%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Park Medi World Ltd

All →